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Liquisolid system has been used to increase the dissolution rate of hydrophobic 
drugs. Since drug solubility play an important role in drug release profile, using 
appropriate solvent can lead the system to become sustain release. The aim of this 
study was to investigate the effect of different liquid vehicles and Eudragit RSPO on 
release characteristics of atorvastatin as a hydrophobic drug. 
 
Methods and Results:  
Several Liquisolid compacts with Propylene glycol and tween80 with different drug 
solvent ratio was prepared. The ratio of the carrier material (Eudragit RSPO: 
microcrystalline cellulose, (60:40)), for coating material (silica) was 2 in all 
formulations. To evaluate any interaction between atorvastatin and the other 
components, the differential scanning calorimeter (DSC) and Fourier transform 
infrared spectroscopy (FTIR) was used. Atorvastatin Liquisolid compacts containing 
Propylene glycol and tween80 as liquid vehicle increased dissolution rate of drug 
from 23.75±0.33 (in conventional matrix formulation) to 38.66±1.77 and 99.95±4.2 
respectively, in first 480 minute. By increasing the ratio of tween80 to drug from 1:1 
to 4:1 reduced drug retardation was seen, consequently the release percentage 
increased from 60.50±3.1 to 99.95±4.2. This was contrary to propylene glycol drug 
formulation. The resultant difference in effect of formulations was probably due to 
more solubility of atorvastatin in tween80 (26.77 g/100ml) in comparison to 
Propylene glycol (11.65 g/100ml). It was observed that a slight change on carrier 
(55.66 increased to 57.54%) and drug percentage (3.15% decreased to 2.59%) in 
formulation with Tween80:drug ratio (4:1), presented more retardation effect so that 
release percentage decreased from 99.95±4.2 to 75.92± 2.20. All formulations had 
hardness and friability between (35.6±0.57 - 43.4±1.14) N and (0.67% - 1.3%), 
respectively. The DSC, FTIR and X-ray evaluations revealed no interaction between 
drug and excipients. 
 
Conclusions: 
The liquisolid compacts with the suitable carrier can be promising technique to 
sustain release drugs, in addition, type of nonvolatile solvent has an important effect 
on liquisolid release profile. 
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